Viela Bio, Inc.
DelistedCIK 1734517fmd_1G9YE8CW8HVDHQDFPYAWGCZJSVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2020, 12 periods
Latest annual · FY2020
Millions- Total revenues
- 12
- Operating income
- (154)
- Net income
- (151)
- Free cash flow
- (107)
Latest quarter · Q4 FY2020
Millions- Total revenues
- 9
- Operating income
- (34)
- Net income
- (33)
- Free cash flow
- (9)
Viela Bio, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2020 | FY2019 | Change | Source |
|---|---|---|---|---|
| Revenue | $11.7 million | $50 million | -76.7% | 10-K 2021-03-01 · proof |
| Operating income | -$153.9 million | -$89.7 million | 10-K 2021-03-01 · proof | |
| Net income | -$150.7 million | -$86.4 million | 10-K 2021-03-01 · proof | |
| Cash from operating activities | -$106.1 million | -$105 million | 10-K 2021-03-01 · proof | |
| Free cash flow | -$107 million | -$106.2 million | 10-K 2021-03-01 · proof | |
| Total assets | $423.3 million | $384.1 million | +10.2% | 10-K 2021-03-01 · proof |
| Total liabilities | $47.4 million | $29.5 million | +60.5% | 10-K 2021-03-01 · proof |
| Cash and cash equivalents | $130.1 million | $200.9 million | -35.2% | 10-K 2021-03-01 · proof |
- What was Viela Bio, Inc.'s revenue in fiscal 2020?
- Viela Bio, Inc. reported revenue of $11.7 million for fiscal 2020 (the year ended Dec 31, 2020), against $50 million the year before (-76.7%). Source: the 10-K filed with the SEC on Mar 1, 2021. SEC
- What was Viela Bio, Inc.'s operating income in fiscal 2020?
- Viela Bio, Inc. reported operating income of -$153.9 million for fiscal 2020 (the year ended Dec 31, 2020), against -$89.7 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2021. SEC
- What was Viela Bio, Inc.'s net income in fiscal 2020?
- Viela Bio, Inc. reported net income of -$150.7 million for fiscal 2020 (the year ended Dec 31, 2020), against -$86.4 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2021. SEC
- What was Viela Bio, Inc.'s cash from operating activities in fiscal 2020?
- Viela Bio, Inc. reported cash from operating activities of -$106.1 million for fiscal 2020 (the year ended Dec 31, 2020), against -$105 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2021. SEC
- What was Viela Bio, Inc.'s free cash flow in fiscal 2020?
- Viela Bio, Inc. reported free cash flow of -$107 million for fiscal 2020 (the year ended Dec 31, 2020), against -$106.2 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2021. SEC
- What are Viela Bio, Inc.'s total assets?
- As of Dec 31, 2020, Viela Bio, Inc. reported total assets of $423.3 million, against $384.1 million a year earlier (+10.2%). Source: the 10-K filed with the SEC on Mar 1, 2021. SEC
- What are Viela Bio, Inc.'s total liabilities?
- As of Dec 31, 2020, Viela Bio, Inc. reported total liabilities of $47.4 million, against $29.5 million a year earlier (+60.5%). Source: the 10-K filed with the SEC on Mar 1, 2021. SEC
- What are Viela Bio, Inc.'s cash and cash equivalents?
- As of Dec 31, 2020, Viela Bio, Inc. reported cash and cash equivalents of $130.1 million, against $200.9 million a year earlier (-35.2%). Source: the 10-K filed with the SEC on Mar 1, 2021. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1734517&period_type=annual&limit=5"Information only, not investment advice.